AstraZeneca scours supply chain for more vaccine doses in Southeast Asia

by Matthew Escosia
SEA Wave - Astrazeneca COVID-19 vaccine
Spread the love

By: Mabel Villanueva


Amidst the speculation of production shortage, AstraZeneca announced that they are scouring their global supply chain for COVID-19 vaccine to boost supplies in Southeast Asia.

The company, in accordance with an agreement with Thai officials, will produce 180 million doses – one-third of which will be for Thailand’s domestic use while the rest is for exportation to neighboring countries including Indonesia, the Philippines, and Malaysia.

SEA Wave - Astrazeneca COVID-19 vaccine

Photo from Agence France-Presse/Andrew Matthews

AstraZeneca previously said vaccines would come from its Thai partner Siam Bioscience, a first-time vaccine maker, who has not given a statement on reports of production shortfalls and delayed deliveries.

“We are delivering in the fastest possible timeframe, however, given the gravity of the Delta variant, we are leaving no stone unturned to accelerate supply further still,” James Teague, managing director of AstraZeneca Thailand, said in a statement. “We are hopeful of importing additional doses in the months ahead.”

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Skip to content